The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Taiho Pharmaceutical
Phase I study of the Aurora A kinase (AurA) inhibitor TAS-119 with paclitaxel (P) in advanced solid tumors.
 
Dana Backlund Cardin
Consulting or Advisory Role - Abbvie; Rafael Pharmaceuticals
Research Funding - Advaxis (Inst); Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); EMD Serono (Inst); Incyte (Inst); Lilly (Inst); Synta (Inst)
Travel, Accommodations, Expenses - Abbvie
 
Haeseong Park
Research Funding - Ambrx (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); Macrogenics (Inst); MedImmune (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Regeneron (Inst); Roche (Inst); Taiho Pharmaceutical (Inst); Vertex (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - Bayer
 
Jennifer Robinson Diamond
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Immunomedics (Inst); MedImmune (Inst); Merck (Inst); Millennium (Inst); OncoMed (Inst); Rexahn Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Alexander E. Drilon
Honoraria - Foundation Medicine; Medscape; MORE Health; OncLive; Peerview; PeerVoice; Physicans' Education Resource; Research to Practice; Targeted Oncology
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; BerGenBio; Blueprint Medicines; Exelixis; Genentech/Roche; Helsinn Therapeutics; Hengrui Therapeutics; Ignyta; Loxo; MORE Health; Pfizer; Takeda/Millennium; TP Therapeutics; Tyra Biosciences; Verastem
Patents, Royalties, Other Intellectual Property - Wolters Kluwer (Royalties for Pocket Oncology)
Other Relationship - GlaxoSmithKline; Merck; Taiho Pharmaceutical; Teva
 
Wendy L. VerMeulen
No Relationships to Disclose
 
Xiaomin He
Employment - Taiho Pharmaceutical
 
Hiroshi Hirai
Employment - Taiho Pharmaceutical
Stock and Other Ownership Interests - Otsuka
Patents, Royalties, Other Intellectual Property - Taiho Pharmaceutical
 
Nital Soni
No Relationships to Disclose
 
Jordan Berlin
Honoraria - Nestle health science
Consulting or Advisory Role - Abbvie; Arno Therapeutics; AstraZeneca; Bayer Health; BeiGene; Celgene; Cornerstone Pharmaceuticals; Eisai; EMD Serono; ERYTECH Pharma; Exelixis; Five Prime Therapeutics; Genentech/Roche; Gritstone Bio; Karyopharm Therapeutics; lsk biopharma; Seagen
Research Funding - Bayer (Inst); BeiGene (Inst); boston biomedical (Inst); EMD Serono (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Loxo (Inst); Macrogenics (Inst); Pharmacyclics (Inst); Symphogen (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Abbvie; Bayer; EMD Serono; Nestle health science; Seagen
Other Relationship - AstraZeneca